Editor’s PicksA Comorbidity-based Screening Tool to Predict Severe Maternal Morbidity at the Time of DeliveryEaster, S.R.; Bateman, B.T.; Sweeney, V.H.; Manganaro, K.; Lassey, S.C.; Gagne, J.J.; Robinson, J.N.Author Information Division of Maternal-Fetal Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA Obstetric Anesthesia Digest: June 2020 - Volume 40 - Issue 2 - p 53-54 doi: 10.1097/01.aoa.0000660628.05807.e7 Buy Metrics Abstract (Am J Obstet Gynecol. 2019;221:271.e1–271.e10) An important strategy for improving maternal health is development of a tool that reliably identifies women at risk of severe maternal morbidity (SMM) and death. The obstetric comorbidity index (OB-CMI) summarizes the burden of maternal comorbidities and allows for the generation of a single numeric score to quantify risk assessment. While the OB-CMI was originally designed to address bias in research studies, the authors hypothesized it could be adapted for clinical use. The score is calculated from a 20-item list of comorbidities (eg, preeclampsia, multiple gestation, asthma, advanced maternal age). The comorbidities are weighted (eg, preeclampsia with severe features is 5 points, diabetes on insulin is 1 point). The points are summed for a total score. The aim of this study was to prospectively evaluate the performance of this comorbidity index as a screening tool to accurately identify laboring women at risk of SMM. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.